SARS-CoV-2-IN-13 [56961-10-5]

TargetMol Chemicals

SARS-CoV-2-IN-13 [56961-10-5]

4

Chemical

Research Use Only

SARS-CoV-2-IN-13

98.15%

C13H8Cl2N2O4

327.12

SARS-CoV-2-IN-13 (compound 5) is an analogue of niclosamide, displaying greater stability in human plasma and liver S9 enzymes assay. It improves bioavailability and half-life when administered orally and is a potent SARS-CoV-2 inhibitor with an IC50 of 0.057 microM [1].

3 years

Oc1ccc(Cl)cc1C(=O)Nc1ccc(c(Cl)c1)[N+]([O-])=O

-20°C

51202000